CN201926664U - Kit for immunoblot assay of specific IgG antibody against Treponema pallidum - Google Patents
Kit for immunoblot assay of specific IgG antibody against Treponema pallidum Download PDFInfo
- Publication number
- CN201926664U CN201926664U CN 201120025698 CN201120025698U CN201926664U CN 201926664 U CN201926664 U CN 201926664U CN 201120025698 CN201120025698 CN 201120025698 CN 201120025698 U CN201120025698 U CN 201120025698U CN 201926664 U CN201926664 U CN 201926664U
- Authority
- CN
- China
- Prior art keywords
- treponema pallidum
- recombinant antigen
- syphilis
- kit
- igg antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Landscapes
- Peptides Or Proteins (AREA)
Abstract
The utility model relates to a kit, in particular to a kit for immunoblo assay of a specific IgG antibody against Treponema pallidum (TP). The kit comprises a carrier plate, a nitrocellulose membrane, a Treponema pallidum specific IgG antibody test line and a control line, wherein the Treponema pallidum specific IgG antibody test line and the control line are arranged in sequence on the nitrocellulose membrane; the Treponema pallidum specific IgG antibody test line is coated with a Treponema pallidum specific recombinant antigen; the control line is coated with a human IgG antibody, preferably a horseradish peroxidase-labeled anti-human gamma-chain antibody; and the Treponema pallidum specific recombinant antigen is Treponema pallidum specific recombinant antigen TPN15, Treponema pallidum specific recombinant antigen TPN17, Treponema pallidum specific recombinant antigen TPN37, Treponema pallidum specific recombinant antigen TPN44.5 or Treponema pallidum specific recombinant antigen TPN47. The kit can be applied to detect the Treponema pallidum specific IgG antibody in the whole blood sample, the blood serum sample, the blood plasma sample and the cerebrospinal fluid sample, and has the advantages of minimum sample amount, no need of special instruments, simple and rapid detection, strong specificity, high sensitivity, high accuracy and reliability and low cost.
Description
Technical field
The utility model relates to a kind of kit, especially relates to a kind of syphilis specific IgG antibodies and detects HP immunoblotting kit.
Background technology
Syphilis (Syphilis) is that a kind of (its pathogen is a microspironema pallidum for Treponema pallidum, the sexually transmitted disease that TP) causes, belongs to Spirochaetaceae by microspironema pallidum.Approach such as the main trafficability characteristic contact of microspironema pallidum, blood transfusion, wound or placenta are propagated.Microspironema pallidum enters blood near the lymph node the infected area, sends out whole body, and nearly all tissue of body and organ are got involved, and clinical manifestation is a general, can be divided into different clinical stages, comprises first phase, second phase, three phases and latent period.The World Health Organization (WHO) is prophesy optimistically once: " because high sensitivity detection method and therapeutic scheme are efficiently arranged, syphilis is a kind of sexually transmitted disease that can succeed and control by the public health measure ".Regrettably, so far syphilis still is worldwide public health problem, lack effective administrative control measure, annual nearly 1,200 ten thousand the patient in the whole world, 600,000 pregnant woman patients ([1] Lin Lirong, Yang Bo, Pan Xitao wherein, Deng. the selection of patient's syphilis serology detection method is propagated in potential blood source. Chinese hospital infection magazine .2010,20 (10): 1491-1494).In fact, the infection present situation of syphilis is possibly than more allowing people's pessimism in the imagination.
Investigation finds that syphilis the person be present among the general population more widely.
Microspironema pallidum still can not carry out in vitro culture, and controller used in syphilis diagnosis and epidemiology survey mainly depend on serological test, comprises that specific antibody and reagin detect two major types.Syphilis specific antibody IgM (TP-IgM) and IgG (TP-IgG) antibody are respectively at 2 weeks and the back generation of 4 weeks, even the patient is through enough treatments, it still can long-term existence, even ([2] Lin Lirong that do not disappear all the life, but ice, Fu Zuogen, etc. patient syphilis serology TRUST/TPPA and the antibody combined detection of IgM are propagated in potential blood source. Chinese skin cypridology magazine .2010,152 (05): 446-448); And that another kind of antibody materials reagin produces is later, generally produce in 5～7 weeks of infected back, and late syphilis, syphilis treatment later stage and latent syphilis may be negative, so the positive rate of syphilis specific antibody, susceptibility is significantly higher than reagin.After TP-IgM is syphilis, the specific antibody that body occurs at first.As long as there is microspironema pallidum alive to exist, its TP-IgM will maintain certain level.([3] Martina H such as MartinaH, Daan W N, Mart M, et al.Comparison of a Treponema pallidum IgM immunoblot with a 19Sfluorescent treponemal antibody absorption test for the diagnosis of congenital syphilis[J] Diagnostic Microbiology and Infectious Disease, 2007,59:61-66.) think that TP-IgM is a syphilis early infection and a movable serologic marker, ([4] Li Burong such as Li Burong, He Juntao, Zhang Yi, Deng. the clinical meaning [J] of microspironema pallidum IgM antibody test. The Fourth Military Medical University's journal, 2007,28 (16): 1495-1497) think that TP-IgM is the same with TP-DNA, representing syphilis infectiousness index.Under the prerequisite of the recent anti-syphilis treatment of eliminating, TP-IgM is not if turn out cloudy, and remaining microspironema pallidum of possibility or treatment are not thorough in the prompting body.The cloudy commentaries on classics person of TP-IgM changes positive when following up a case by regular visits to again, show once more syphilization ([5] Rawstron SA, Mehta S, Bromberg K, et al.Evaluation of a Treponema pallidum2specificIgM enzyme immunoassay and Treponema pallidum western blot antibody detection in the diagnosis ofmaternal and congenital syphilis[J] .Sex Transm Dis, 2004,31 (2): 123-126).Although the TP-IgM feminine gender can not be got rid of infectiousness fully, the TP-IgM positive must point out this patient to have infectiousness.The appearance of TP-IgG will be later than IgM, the energy long-term existence, even do not disappear all the life, therefore, TP-IgG is an important indicator ([6] Li-Rong Lin of controller used in syphilis diagnosis and epidemiology survey, Zuo-Gen Fu, Bing Dan, et al.Development of a colloidal gold-immunochromatography assay to detect Immunoglobulin G Antibodies to Treponema pallidum with TPN17 and TPN47.Diagnostic Microbiology and Infectious Disease, 2010,68:193-200.).
Early stage serological method uses complete microspironema pallidum as antigen, the TP of research and diagnosis usefulness obtains with TP infected rabbits testis, this method exists that cost is big, the TP amount that obtains less and impure (being mixed with host protein), have shortcomings such as cross reaction with other pathogen, so false positive also happens occasionally.Along with the clone in succession who reaches treponemal antigen that popularizes of Protocols in Molecular Biology, it is more and more that recombinant antigen is applied to the syphilis experiment.The many TP antigen of research has TPN17, TPN47, TPN15, TPN44.5, TPN36, TP0453, TP0684 and TPr family at present.The recombinant antigen that adopts recombinant DNA technology to prepare can overcome the shortcoming of complete TP antigen, can prepare endless special reorganization TP antigen fast, economically.
The syphilis specific IgG antibodies detection method comprises microspironema pallidum specific antibody GAT (TPPA), enzyme linked immunosorbent assay (ELISA), FTA-ABS test (FTA-ABS) and immunoblot assay (Western-Blot) etc., and its specificity is all higher.Usually, TPPA, ELISA be as clinical primary dcreening operation, and when the serology positive, or clinical diagnosis needs to adopt FTA-ABS and Western-blot as validation test when having any problem.Wherein, FTA-ABS needs fluorescent microscope, and its result judges and need do some training very often and just can finish than the professional of rich experiences that therefore, its application is subjected to certain restriction.The kit that adopts the Western-blot method to make, general Routine Test Lab all can be finished, and does not need specific installation, and interpretation is also simple and clear.Existing commercially available Western-blot reagent is import reagent, costs an arm and a leg.
Summary of the invention
The purpose of this utility model provides a kind of syphilis specific IgG antibodies HP immunoblotting kit.
The utility model is provided with carrier board, nitrocellulose membrane, syphilis specific IgG antibodies detection line, control line, and syphilis specific IgG antibodies detection line and control line are located on the nitrocellulose membrane successively; , wrapped by the human IgG antibody by the syphilis specific recombinant antigen at syphilis specific IgG antibodies detection line place bag at the control line place; The anti-people γ of horseradish peroxidase-labeled chain antibody.
Described syphilis specific recombinant antigen is TPN15, TPN17, TPN37, TPN44.5, TPN47 syphilis specific recombinant antigen.
Described carrier board can adopt the PVC plate.
Described syphilis specific IgG antibodies HP immunoblotting kit can adopt following method preparation:
1) preparation syphilis specific recombinant antigen
Adopt gene clone technology, the DNA of pcr amplification coding treponemal antigen, and make its expression in the insertion Escherichia coli, get the syphilis specific recombinant antigen.
2) point sample of nitrocellulose filter
Bag by the human IgG antibody, is dried at control line place bag by the syphilis specific recombinant antigen on nitrocellulose filter IgG detection line, and described syphilis specific recombinant antigen and human IgG antibody's concentration can be 1～4mg/mL; The point sample amount can be 1 μ L/cm.
3) the anti-human IgG specific fragment γ chain monoclonal antibody of preparation
With human IgG specific fragment γ chain is antigen immune Balb/c mouse, and by hybridoma technology, screening obtains the hybridoma cell strain of the anti-human IgG monoclonal antibody of stably excreting, adopts the method identification of M cAb of ELISA to tire at 1: 10
7More than.
4) horseradish peroxidase (HRP) mark of anti-human IgG specific fragment γ chain monoclonal antibody
Adopt the sodium periodate method to carry out horseradish peroxidase (HRP) mark, the substrate of described horseradish peroxidase can be made up of the diaminobenzidine of the hydrogen peroxide and 0.07% (W/V) of 0.03% (W/V).
5) preparation HP immunoblotting kit
Nitrocellulose membrane is sticked on the carrier board upper surface, syphilis specific IgG antibodies detection line and control line are located on the nitrocellulose membrane successively, wrap by the syphilis specific recombinant antigen at syphilis specific IgG antibodies detection line place, wrap coated human IgG antibody at the control line place, be cut into strip with cutting cutter, dress up the syphilis specific IgG antibodies HP immunoblotting kit with the anti-people γ chain monoclonal antibody and the substrate mutual group thereof of enzyme labeling.
In step 1), 2), 5) in, described syphilis specific recombinant antigen can be TPN15, TPN17, TPN37, TPN44.5, TPN47 syphilis specific recombinant antigen etc.
The utility model provides a kind of employing immunoblot assay to set up syphilis specific IgG antibodies detectable bar, can be used for the detection of syphilis specific IgG antibodies in the samples such as whole blood, serum, blood plasma and cerebrospinal fluid.The required specimen amount of this detection method is minimum, does not need specific apparatus, the direct sentence read result of naked eyes, and detect easy fast, high specificity, highly sensitive, accurately and reliably, cost is low, is widely used.
Description of drawings
Fig. 1 is that the structure of the utility model embodiment is formed synoptic diagram.
Fig. 2 is the experimental result pattern diagram.In Fig. 2, I is the synoptic diagram before using, and H is invalid test (product quality problem), the negative result of G, and A～F is the TP-IgG positive findings; 2 is syphilis specific TPN-15-IgG antibody detection line, 3 is syphilis specific TPN-17-IgG antibody detection line, 4 is syphilis specific TPN-37-IgG antibody detection line, 5 is syphilis specific TPN-44.5-IgG antibody detection line, 6 is syphilis specific TPN-47-IgG antibody detection line, and 7 is control line.
Embodiment
Following examples will be further described the utility model in conjunction with the accompanying drawings.
Referring to Fig. 1, the utility model embodiment is provided with carrier board 1, syphilis specific IgG antibodies detection line 2～6, control line 7 and nitrocellulose membrane (NC film) 8.
Nitrocellulose membrane 8 sticks on carrier board 1 upper surface, and syphilis specific IgG antibodies detection line 2～6 and control line 7 are located on the nitrocellulose membrane 8 successively; Wrap respectively by syphilis specific recombinant antigen TPN15, TPN17, TPN37, TPN44.5 and TPN47 at syphilis specific IgG antibodies detection line place, wrap by the human IgG antibody at control line 7 places.
Described carrier board adopts the PVC plate.
The preparation method of described syphilis specific IgG antibodies HP immunoblotting kit may further comprise the steps:
1) preparation TPN15, TPN17, TPN37, TPN44.5 and TPN47 syphilis specific recombinant antigen
Adopt gene clone technology, the DNA of pcr amplification coding treponemal antigen, and make its expression in the insertion Escherichia coli, get TPN15, TPN17, TPN37, TPN44.5 and TPN47 syphilis specific recombinant antigen.
2) point sample of nitrocellulose filter
Bag by the human IgG antibody, is dried at control line place bag by TPN15, TPN17, TPN37, TPN44.5, TPN47 syphilis specific recombinant antigen on nitrocellulose filter IgG detection line.
3) the anti-human IgG specific fragment γ chain monoclonal antibody of preparation
With human IgG specific fragment γ chain is antigen immune Balb/c mouse, and by hybridoma technology, screening obtains the hybridoma cell strain of the anti-human IgG monoclonal antibody of stably excreting.Adopt the method identification of M cAb of ELISA to tire at 1: 10
7More than.
4) horseradish peroxidase (HRP) mark of anti-human IgG specific fragment γ chain monoclonal antibody
Adopt the sodium periodate method to carry out horseradish peroxidase (HRP) mark.
5) preparation HP immunoblotting kit
Nitrocellulose membrane is sticked on the carrier board upper surface, and syphilis specific IgG antibodies detection line and control line are located on the nitrocellulose membrane successively; Wrap by syphilis specific recombinant antigen TPN15, TPN17, TPN37, TPN44.5, TPN47 at syphilis specific IgG antibodies detection line place, wrap by the human IgG antibody at the control line place, the anti-people γ chain monoclonal antibody and the substrate mutual group thereof that are cut into strip and enzyme labeling with cutting cutter are dressed up the syphilis specific IgG antibodies HP immunoblotting kit.
Below provide the clinical samples that adopts the syphilis specific IgG antibodies HP immunoblotting kit to detect the patient:
1) sample adopts 0.01mol/L PBS damping fluid to carry out dilution in 1: 50.
2) sealing: adopt 5% skimmed milk power (preparation of 0.01mol/LPBST damping fluid) as confining liquid, waving incubation 30min on the shaking table in room temperature (18～25 ℃).
3) serum incubation: take out required film bar, put it in the incubation groove, and numbering.In the incubation groove, add 1.5ml diluted sample respectively.Waving incubation 30min on the shaking table in room temperature (18～25 ℃).
4) clean: inhale and remove liquid in the groove, waving on the shaking table with 1.5ml 0.01mol/L PBS buffer solution for cleaning film bar 3 times each 5min.
5) add enzyme conjugates: in the incubation groove, add the enzyme conjugates (the anti-human IgG specific fragment γ chain monoclonal antibody that adopts horseradish peroxidase-labeled is for detecting antibody) that 1.5ml has diluted, waving incubation 30min on the shaking table in room temperature (18～25 ℃).
6) clean: inhale and remove liquid in the groove, waving on the shaking table with 1.5ml 0.01mol/L PBS buffer solution for cleaning film bar 3 times each 5min.
7) substrate incubation: in the incubation groove, add 1.5ml substrate solution (DAB) respectively, waving incubation 10min on the shaking table in room temperature (18～25 ℃).
8) stop: inhale and remove liquid in the groove, clean the film bar 3 times, each 1min with distilled water.
The result judges: will detect the film bar and be placed on the result and judge in the template air-dry judged result afterwards.Any protein targets marks existing specific band, all can be judged as the positive, is diagnosed as the syphilis (see figure 2).
Below provide the performance calibrating of syphilis specific IgG antibodies HP immunoblotting kit:
1) visual examination: kit does not have breakage, and bag is by smooth, the clean pollution-free spot of reaction film, free from flaw, and adhesive tape does not have and comes unglued, and does not have and cuts oblique phenomenon.
2) positive sample coincidence rate: use the positive control serum of the different titers of the TP-IgG positive to adopt the calibrating of syphilis specific IgG antibodies HP immunoblotting kits for each 50 parts, calculate positive coincidence rate.The clinical samples that definite employing FTA-ABS of positive control serum (German Ou Meng company) method is determined.
3) negative sample coincidence rate:, calculate positive coincidence rate with 50 parts of negative control serum calibratings.The clinical samples that definite employing TPPA (Japanese fuji Co., Ltd.) method of negative control serum is determined.
4) criticize interior difference: same batch of syphilis specific IgG antibodies HP immunoblotting kit, detect with characteristic serum, require the shade unanimity of positive serum testing result demonstration colour band, the feminine gender as a result that negative serum detects.
5) differences between batches: different batches syphilis specific IgG antibodies HP immunoblotting kit, detect with characteristic serum, require the shade unanimity of positive serum testing result demonstration colour band, the feminine gender as a result that negative serum detects.
6) interference test: testing result is not subjected to the interference of sample hemolysis (n=50), piarhemia (n=50) and jaundice (n=50).
7) cross reaction: adopt this syphilis specific IgG antibodies HP immunoblotting kit, carry out the detection of systemic loupus erythematosus (n=30), rheumatoid disease (n=30), autoallergic autoimmunity systemic diseases such as (n=30), do not find cross reaction.
8) Detection of Stability: use the Arrhenius rule, the syphilis specific IgG antibodies HP immunoblotting kit placed 37 ℃ detect after 20 days, more than every index do not have marked change, guarantee that finished product preserves under the drying at room temperature condition, the term of validity is 18 months.
Below provide specific embodiment.
Embodiment 1
Nitrocellulose membrane is sticked on the carrier board upper surface, and syphilis specific IgG antibodies detection line and control line are located on the nitrocellulose membrane successively; Wrap by syphilis specific recombinant antigen TPN15, TPN17, TPN37, TPN44.5, TPN47 at syphilis specific IgG antibodies detection line place, wrap by the human IgG antibody at the control line place, the anti-people γ chain monoclonal antibody and the substrate mutual group thereof that are cut into strip and enzyme labeling with cutting cutter are dressed up the syphilis specific IgG antibodies HP immunoblotting kit.
1) sample adopts 0.01mol/L PBS damping fluid to carry out dilution in 1: 50.
2) sealing: adopt 5% skimmed milk power (preparation of 0.01mol/LPBST damping fluid) as confining liquid, waving incubation 30min on the shaking table in room temperature (18～25 ℃).
3) serum incubation: take out required film bar, put it in the incubation groove, and numbering.In the incubation groove, add 1.5ml diluted sample respectively.Waving incubation 30min on the shaking table in room temperature (18～25 ℃).
4) clean: inhale and remove liquid in the groove, waving on the shaking table with 1.5ml 0.01mol/L PBS buffer solution for cleaning film bar 3 times each 5min.
5) add enzyme conjugates: in the incubation groove, add the enzyme conjugates (the anti-human IgG specific fragment γ chain monoclonal antibody that adopts horseradish peroxidase-labeled is for detecting antibody) that 1.5ml has diluted, waving incubation 30min on the shaking table in room temperature (18～25 ℃).
6) clean: inhale and remove liquid in the groove, waving on the shaking table with 1.5ml 0.01mol/L PBS buffer solution for cleaning film bar 3 times each 5min.
7) substrate incubation: in the incubation groove, add 1.5ml substrate solution (DAB) respectively, waving incubation 10min on the shaking table in room temperature (18～25 ℃).
8) stop: inhale and remove liquid in the groove, clean the film bar 3 times, each 1min with distilled water.
The result judges: will detect the film bar and be placed on the result and judge in the template air-dry judged result afterwards.Any protein targets marks existing specific band, all can be judged as the positive, is diagnosed as the syphilis (see figure 2).
Similar to embodiment 1, its difference is that the nitrocellulose membrane detection line only is made up of TPN15, TPN17, TPN37, TPN44.5 syphilis specific recombinant antigen, does not contain TPN47 syphilis specific recombinant antigen.The result judges identical with embodiment 1.
Similar to embodiment 1, its difference is that the nitrocellulose membrane detection line only is made up of TPN15, TPN17, TPN37, TPN47 syphilis specific recombinant antigen, does not contain TPN44.5 syphilis specific recombinant antigen.The result judges identical with embodiment 1.
Similar to embodiment 1, its difference is that the nitrocellulose membrane detection line only is made up of TPN15, TPN17, TPN44.5, TPN47 syphilis specific recombinant antigen, does not contain TPN37 syphilis specific recombinant antigen.The result judges identical with embodiment 1.
Similar to embodiment 1, its difference is that the nitrocellulose membrane detection line only is made up of TPN15, TPN37, TPN44.5, TPN47 syphilis specific recombinant antigen, does not contain TPN17 syphilis specific recombinant antigen.The result judges identical with embodiment 1.
Similar to embodiment 1, its difference is that the nitrocellulose membrane detection line only is made up of syphilis specific recombinant antigen TPN17, TPN37, TPN44.5, TPN47, does not contain syphilis specific recombinant antigen TPN15.The result judges identical with embodiment 1.
Similar to embodiment 1, its difference is that sample to be checked is a samples of CSF, and the result judges identical with embodiment 1.
Embodiment 8
The performance verification test: the scheme by embodiment 1 prepares the syphilis specific IgG antibodies HP immunoblotting kit, carries out performance verification then.
1) visual examination: kit does not have breakage, and bag is by smooth, the clean pollution-free spot of reaction film, free from flaw, and adhesive tape does not have and comes unglued, and does not have and cuts oblique phenomenon.
2) positive sample coincidence rate: use the positive reference sample of the different titers of the TP-IgG positive to adopt the calibrating of syphilis specific IgG antibodies HP immunoblotting kits for each 50 parts, calculate positive coincidence rate.The clinical samples that definite employing FTA-ABS of positive reference sample (German Ou Meng company) method is determined.
3) negative sample coincidence rate:, calculate positive coincidence rate with 50 parts of negative reference sample calibratings.The clinical samples that definite employing TPPA (Japanese fuji Co., Ltd.) method of negative reference sample is determined.
4) criticize interior difference: same batch of syphilis specific IgG antibodies HP immunoblotting kit, detect with the characteristic sample, require the shade unanimity of positive sample testing result demonstration colour band, the feminine gender as a result that negative sample detects.
5) differences between batches: different batches syphilis specific IgG antibodies HP immunoblotting kit, detect with the characteristic sample, require the shade unanimity of positive sample testing result demonstration colour band, the feminine gender as a result that negative sample detects.
6) cross reaction: adopt this syphilis specific IgG antibodies HP immunoblotting kit, carry out the detection of systemic loupus erythematosus (n=30), rheumatoid disease (n=30), autoallergic autoimmunity systemic diseases such as (n=30), do not find cross reaction.
7) Detection of Stability: use the Arrhenius rule, the syphilis specific IgG antibodies HP immunoblotting kit placed 37 ℃ detect after 20 days, more than every index do not have marked change, guarantee that finished product preserves under the drying at room temperature condition, the term of validity is 18 months.
Claims (3)
1. the syphilis specific IgG antibodies HP immunoblotting kit is characterized in that being provided with carrier board, nitrocellulose membrane, syphilis specific IgG antibodies detection line, control line, and syphilis specific IgG antibodies detection line and control line are located on the nitrocellulose membrane successively; , wrapped by the human IgG antibody by the syphilis specific recombinant antigen at syphilis specific IgG antibodies detection line place bag at the control line place; The anti-people γ of horseradish peroxidase-labeled chain antibody.
2. syphilis specific IgG antibodies HP immunoblotting kit as claimed in claim 1 is characterized in that described syphilis specific recombinant antigen is TPN15, TPN17, TPN37, TPN44.5, TPN47.
3. syphilis specific IgG antibodies HP immunoblotting kit as claimed in claim 1 is characterized in that described carrier board adopts the PVC plate.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201120025698 CN201926664U (en) | 2011-01-25 | 2011-01-25 | Kit for immunoblot assay of specific IgG antibody against Treponema pallidum |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201120025698 CN201926664U (en) | 2011-01-25 | 2011-01-25 | Kit for immunoblot assay of specific IgG antibody against Treponema pallidum |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN201926664U true CN201926664U (en) | 2011-08-10 |
Family
ID=44430508
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201120025698 Expired - Fee Related CN201926664U (en) | 2011-01-25 | 2011-01-25 | Kit for immunoblot assay of specific IgG antibody against Treponema pallidum |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN201926664U (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102095860A (en) * | 2011-01-25 | 2011-06-15 | 厦门大学附属中山医院 | Western blot kit for specific IgG antibodies of syphilis and preparation method thereof |
| CN104155450A (en) * | 2014-08-20 | 2014-11-19 | 厦门大学附属中山医院 | Treponema pallidum IgG antibody biotin avidin enzyme-linked immune detection kit and preparation method thereof |
| US11167283B2 (en) | 2018-05-04 | 2021-11-09 | University Of South Carolina | Dot blot box and use thereof |
-
2011
- 2011-01-25 CN CN 201120025698 patent/CN201926664U/en not_active Expired - Fee Related
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102095860A (en) * | 2011-01-25 | 2011-06-15 | 厦门大学附属中山医院 | Western blot kit for specific IgG antibodies of syphilis and preparation method thereof |
| CN102095860B (en) * | 2011-01-25 | 2013-12-18 | 厦门大学附属中山医院 | Syphilis specific IgG antibody western blot kit and preparation method thereof |
| CN104155450A (en) * | 2014-08-20 | 2014-11-19 | 厦门大学附属中山医院 | Treponema pallidum IgG antibody biotin avidin enzyme-linked immune detection kit and preparation method thereof |
| CN104155450B (en) * | 2014-08-20 | 2016-02-17 | 厦门大学附属中山医院 | Microspironema pallidum IgG antibody biotin-labeled pentylamine enzyme-linked immunologic detecting kit and preparation method thereof |
| US11167283B2 (en) | 2018-05-04 | 2021-11-09 | University Of South Carolina | Dot blot box and use thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101738473B (en) | Treponema pallidum antibody diagnostic kit and preparation method thereof | |
| CN101858914B (en) | Reagent strip for testing syphilis specific total antibodies through gold immunochromatographic assay and preparation method thereof | |
| CN101825634A (en) | Reagent strip for joint detection of syphilis specific IgM and IgG antibodies and preparation method thereof | |
| CN103983792B (en) | A kind of immunoglobulin (Ig) lateral chromatography detection system | |
| CN101825636B (en) | Reagent strip for joint detection of syphilis specific IgM antibody and specific total antibody and preparation method thereof | |
| CN101858916A (en) | Reagent strip for testing syphilis specific IgM antibodies through gold immunochromatographic assay and preparation method thereof | |
| CN101825635B (en) | Reagent strip for joint detection of syphilis specific IgG antibody and specific total antibody and preparation method thereof | |
| CN101858915A (en) | Reagent strip for testing syphilis specific IgG antibodies through gold immunochromatographic assay and preparation method thereof | |
| CN201673156U (en) | Colloidal gold immunochromatographic test reagent strip for syphilis specific IgM antibody | |
| CN201926664U (en) | Kit for immunoblot assay of specific IgG antibody against Treponema pallidum | |
| CN102095858A (en) | Western blot kit for cardiolipin and specific IgM antibodies of syphilis and preparation thereof | |
| CN201926662U (en) | Syphilis specificity total antibody immunoblotting kit box | |
| CN201965132U (en) | Syphilis specific IgM antibody immunoblotting kit | |
| CN201955343U (en) | Syphilis cardiolipin and specific antibody IgM western-blot kit | |
| CN102095860B (en) | Syphilis specific IgG antibody western blot kit and preparation method thereof | |
| CN102368068B (en) | Kit for detecting chlamydia pneumoniae IgM antibody | |
| CN201926663U (en) | Immunoblotting kit for cardiolipin antibodies and syphilis specific immunoglobulin G (IgG) antibodies | |
| CN102081096A (en) | Syphilis cardiolipin and specific antibody IgG (Immunoglobulin G) immunoblotting kit and preparation method thereof | |
| CN202002933U (en) | Syphilis specific total antibody and cardiolipin antibody immunoblotting kit | |
| Blanton et al. | Increased seroprevalence of typhus group rickettsiosis, Galveston County, Texas, USA | |
| CN201673158U (en) | Syphilis specificity IgG antibody collaurum immunity chromatographic detection test strip | |
| CN201697920U (en) | Syphilis specificity IgM antibody and specificity total antibody combined testing reagent strip | |
| CN102095862A (en) | Immune imprinting kit for syphilis specificity IgM antibody and preparation method thereof | |
| CN102095859A (en) | Immunoblotting reagent kit of syphilis specific total antibodies and preparing method thereof | |
| Olut et al. | Diagnostic value of a dot immunobinding assay for human pulmonary hydatidosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110810 Termination date: 20140125 |